Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide crossover study of colonic motility in healthy volunteers
2013-004939-73Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Apr 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of linaclotide (2 arms), sponsored by KU Leuven. Primary endpoints: Motility index during the 8 hours after treatment initiation and Number of high amplitude propagated contractions. Started Apr 2014; status: completed.
02
Drugs
linaclotide
Beyond the preview
Go deeper on 2013-004939-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004939-73.